Joseph H. Korn

Medicine · Health Sciences

40h-index4.8kcitations83works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Sclerosis and Related Diseases(36), Dermatologic Treatments and Research(13), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(10), Skin and Cellular Biology Research(9), Cell Adhesion Molecules Research(8)

Publications83 total

Lymphokines and Cytokines in the Reparative Process
2024
Interaction of Immune and Connective Tissue Cells
2019· 1 cited
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study
Clinical Trials·2009
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double‐blind, placebo‐controlled trial
Arthritis & Rheumatism·2009· 152 citedOpen Access
A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease
Arthritis & Rheumatism·2008· 113 citedOpen Access
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Arthritis Care & Research·2008· 128 citedOpen Access
Human Collagen Krox Up-regulates Type I Collagen Expression in Normal and Scleroderma Fibroblasts through Interaction with Sp1 and Sp3 Transcription Factors
Journal of Biological Chemistry·2007· 52 citedOpen Access
Outcome measurements in scleroderma: results from a delphi exercise.
PubMed·2007· 72 cited
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192
Arthritis & Rheumatism·2006· 449 citedOpen Access
Durometry for the assessment of skin disease in systemic sclerosis
Arthritis Care & Research·2006· 138 cited
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts
Matrix Biology·2006· 80 cited
Increased expression of type I collagen induced by microfibril‐associated glycoprotein 2: Novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma
Arthritis & Rheumatism·2005· 31 cited
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
PubMed·2005· 150 cited
Scleroderma Fibroblasts Demonstrate Enhanced Activation of Akt (Protein Kinase B) In Situ
Journal of Investigative Dermatology·2005· 58 citedOpen Access
Fibulin-2 and Fibulin-5 Alterations in Tsk Mice Associated with Disorganized Hypodermal Elastic Fibers and Skin Tethering
Journal of Investigative Dermatology·2004· 27 cited
Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril‐associated glycoprotein 2 and type I collagen
Arthritis & Rheumatism·2004· 57 cited
Scleroderma: a treatable disease.
Cleveland Clinic Journal of Medicine·2003· 28 cited
Update in systemic sclerosis
Arthritis Care & Research·2003· 3 cited
The role of leukotrienes in alveolitis associated with scleroderma
Arthritis & Rheumatism·2003· 3 cited
Fibrosis in scleroderma
Rheumatic Disease Clinics of North America·2003· 53 cited
page 1 of 5Next →

Frequent Co-authors

Peter A. Merkel(11), Maureen D. Mayes(10), Robert W. Simms(10), James R. Seibold(8), Naomi F. Rothfield(8), Larry W. Moreland(7), Mary Ellen Csuka(6), David H. Collier(6), Fredrick M. Wigley(6), Daniel E. Fürst(6), Virginia Steen(6), Ante Jelaska(6), Vivien Hsu(5), Thomas A. Medsger(5), Eugene Y. Kissin(5), Raphaël Lemaire(5), Daniel E. Furst(4), Dinesh Khanna(4), Michael H. Ellman(4), Sergio A. Jiménez(4)